In Cambodia the infant mortality rate (under 1 year olds) was estimated at 45 per 1000 live births and under 5 mortality rate at 54 per 1000 live births in 2010. The fraction of this burden attributable to bacterial infections in infancy is unknown. In July 2013, an assessment of antimicrobial resistance (AMR) in Cambodia conducted by WHO and the MoH showed that antibiotic resistance has reached alarming levelsThe country faces challenges related to AMR surveillance and laboratory capacity, challenges for ensuring uninterrupted access to essential medicines of assured quality. The regulation and promotion of the rational use of antibiotics in human health is another challenge. In Cambodia, the international ChARLI study will constitute 2 cohorts, one in Phnom Penh, the capital city and one in Kampong Speu province. During the pilot phase, 150 pregnant women will be included and their newborns followed-up for their first six months of life. The study is conducted in collaboration with the Provincial Hospital of Kampong Speu province and the National pediatric hospital in Phnom Penh.
Link to the project website: http://charli.needsolutions.fr/partners_pasteur_cambodia.html